Wednesday saw RBC (TSX:RY) Capital Markets reiterate its optimistic stance on ICON plc (NASDAQ:ICLR), maintaining an Outperform rating and a $263.00 price target. RBC's analysis suggests that ICON is poised for a strong performance in the coming year, anticipating a macroeconomic recovery in the second half of the year.
ICON's shares have seen a significant decline, dropping by more than 25% in recent months due to various temporary factors that have impacted near-term earnings per share (EPS) growth and investor sentiment. With a current market capitalization of $18.38 billion and a P/E ratio of 24.48x, InvestingPro analysis indicates the stock is currently trading below its Fair Value, suggesting potential upside opportunity.
RBC analysts expect these headwinds to diminish, setting the stage for a substantial increase in EPS growth. This anticipated growth is believed to contribute to a revaluation of ICON's stock, which is currently trading near historic lows. The firm's valuation is expected to move towards its historical average of mid to high-teens next twelve months (NTM) EPS.
According to InvestingPro data, ICON maintains a GREAT Financial Health Score of 3.41, with particularly strong marks in profitability metrics. Subscribers can access 6 additional ProTips and comprehensive valuation metrics through the platform's detailed research reports.
ICON's EPS growth has averaged around 12% over the past eight quarters, and while it is projected to slow to approximately 7% in 2025, RBC forecasts a rebound to 12% in 2026.
Historically, ICON's shares have traded above 18 times earnings when forecasted to grow at low double digits (LDDs) on a NTM basis. The $263 price target set by RBC is based on a 2025 estimated price-to-earnings (P/E) ratio of 17.5 times, which includes considerations for what the analyst termed "elevated Trump unknowns."
The firm also notes a favorable comparison with IQVIA Holdings (NYSE:IQV) Inc., another player in the same sector, recognizing that both companies are well-positioned. However, ICON is seen as having a more significant discrepancy in valuation and sentiment, suggesting a higher potential upside as the market for their services recovers.
With revenue growth of 3.63% in the last twelve months and strong cash flow generation, ICON demonstrates solid fundamentals that support its recovery potential.
RBC's analysis indicates confidence in ICON's ability to navigate through the current challenges and emerge with stronger EPS growth. This growth is anticipated to catalyze a positive shift in the stock's valuation, aligning it with historical performance metrics.
In other recent news, ICON plc, a global contract research organization, has been the focus of several significant developments. RBC Capital Markets initiated coverage on ICON, assigning an Outperform rating and setting a price target of $263.00, citing the company's robust financial health and significant role in assisting biopharmaceutical clients.
Despite a recent decline in ICON's stock, the firm anticipates a substantial acceleration in the company's earnings per share (EPS) growth as temporary challenges dissipate.
ICON reported a slight decrease in revenue to $2.03 billion, a 1.2% year-over-year dip, and a decrease in gross business wins by 7.3% to $2.832 billion. However, the company's backlog rose to a record $24.3 billion, marking a 9.4% increase year-over-year. ICON also announced stock repurchases of $100 million and authorized an additional $250 million for buybacks.
The company has appointed Barry Balfe as the new Chief Operating Officer, bringing his extensive leadership experience to this role. Meanwhile, analyst firms Truist Securities and Baird have revised their price targets for ICON to $284 and $242 respectively, influenced by the company's recent financial performance and strategic outlook. These are the recent developments surrounding ICON plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.